Chargement de la fiche…
Chargement de la fiche…
MonRhumato.fr utilise des cookies pour mesurer l'audience (statistiques) et améliorer le site. Aucune donnée de santé identifiable n'est jamais collectée. Politique de confidentialité.
Votre choix est conservé 13 mois (durée max CNIL). Vous pouvez le modifier à tout moment via Préférences cookies.
2 raisons identifiées
Auteur de référence en rhumatologie
28 articles scientifiques publiés — un praticien à la pointe de la recherche
Délais de RDV courts dans la région
73.1 rhumatos / 100 000 hab. — département bien doté
✨ Génération du profil synthétique IA en cours…
CABINET DU DR TAYEB REBBAHI
38 QUAI D'AMONT, 60100 CREIL
Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).
Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
Drug design, development and therapy · 2025
Journal of fluorescence · 2025
Journal of vitreoretinal diseases · 2025
Purpose: To describe a case of radiation retinopathy following craniospinal radiation and provide an overview of studies on radiation retinopathy following whole-brain radiotherapy. Methods: A retrospective chart review was conducted to collect a single patient’s data on demographics, radiation therapy, ophthalmologic examination findings, treatment, and outcomes. For the systematic review, OVID Medline, Embase, and Cochrane CENTRAL were searched for studies reporting on radiation retinopathy following whole-brain radiotherapy. Results: A 24-year-old man with a history of craniospinal radiation presented with proliferative maculopathy. Initial visual acuity was 20/150 in the right eye and 20/40 in the left eye. The patient received monthly intravitreal injections of bevacizumab followed by panretinal laser photocoagulation in both eyes. Maculopathy improved following treatment. Nine articles comprising 13 cases of radiation retinopathy following whole-brain radiotherapy (25 affected eyes; mean ± SD age, 43.3 ± 10.8 years; 46.2% male) were identified by systematic review. None of the patients had diabetes. Radiotherapy was indicated for primary central nervous system lymphoma (6 cases), metastatic spread of breast cancer (4 cases) or lung cancer (2 cases), and acute lymphocytic lymphoma (1 case). The median radiation dose received was 40.7 Gy (range, 30–50). Ten patients had received prior or concurrent chemotherapy. Median time from radiotherapy to symptom onset was 20.5 months (range, 2–216). More than half of patients developed retinopathy bilaterally. Conclusions: To our knowledge, this is the first systematic review to highlight the risk of radiation retinopathy following whole-brain radiotherapy, particularly the increased frequency in patients who have received chemotherapy.
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
Foot & ankle international · 2026 · Journal Article
Almaat A, Elnaggar A, Tayeb K, Fivecoat C, et al.
Bioengineering (Basel, Switzerland) · 2026 · Journal Article
Alsulami AA, Abu Al-Haija Q, Alakhtar R, Alsobhi H, et al.
Cureus · 2026 · Case Reports
Tayeb A, Later S, Nassef M
Scientific reports · 2026 · Journal Article
Adesina OA, Adeniran JA, Ige EO, Abouzied AS, et al.
Biomolecules & biomedicine · 2026 · Journal Article
Ullah MF, Mir R, Javid J, Elfaki I, et al.
ChemistryOpen · 2025 · Journal Article
Abdelrahman AHM, Mekhemer GAH, Sidhom PA, El-Tayeb MA, et al.
Drug design, development and therapy · 2025 · Journal Article
Tayeb SM, Alharbi JA, Alattas BB, Alotaibi DM, et al.
Saudi medical journal · 2025 · Journal Article
Banjer HJ, Tayeb HH, Alzahrani KJ, Alsufiani SM, et al.
Journal of vitreoretinal diseases · 2025 · Journal Article
Sverdlichenko I, Tayeb S, Narmandakh A, Margolin E, et al.
Current research in translational medicine · 2025 · Letter
Garidi R, Aftisse H, Tayeb DS, Benchouk C, et al.
Current pharmaceutical design · 2026 · Journal Article
Felemban MF, Ashour AA, Tayeb FJ, Shafie A
Infectious diseases (London, England) · 2026 · Journal Article
Kusuma IY, Tayeb BA, Zidan MJ, Nurkhasanah S, et al.
Cureus · 2025 · Journal Article
Alhumaid A, Alotaibi A, Tayeb M, Alqhatani Y, et al.
The journal of liquid biopsy · 2025 · Journal Article
Njangiru IK, Tayeb BA, Ali H, Kamil RM
Journal of infection and public health · 2026 · Case Reports
Alzeer S, Almaghrabi RS, Magrashi A, Alzahrani T, et al.
Journal of vitreoretinal diseases · 2025 · Journal Article
Sverdlichenko I, Tayeb S, Cruz Pimentel M, Wahab C, et al.
Molecular syndromology · 2025 · Journal Article
Al-Amer OM, Alasseiri MI, Tayeb FJ, Alanazi MA, et al.
Viruses · 2025 · Journal Article
Mir R, Ullah MF, Elfaki I, Alanazi MA, et al.
The journal of liquid biopsy · 2025 · Journal Article
Njangiru IK, Tayeb BA, Ali H, Kamil RM
Journal of clinical medicine · 2025 · Journal Article
Barausse C, Tayeb S, Sansavini M, Pellegrino G, et al.
Frontiers in medicine · 2026 · Journal Article
Alhazmi AF, Alghuthmi FA, Hamoh MA, Almasari KA, et al.
medRxiv : the preprint server for health sciences · 2025 · Journal Article
Crawford TB, Tayeb M, Barrett E, Al-Saleem T, et al.
Journal of medical virology · 2025 · Journal Article
Saad F, Shams S, Ayaz S, Akbar NU, et al.
Saudi journal of anaesthesia · 2025 · Journal Article
Zabani IA, Alamoudi D, Alhroub K, Alhassoun A, et al.
Cureus · 2025 · Journal Article
Das S, Kotwal V, Thakur A, T L, et al.
Scientific reports · 2026 · Research Support, Non-U.S. Gov't
Elshemy HM, Rady MH, Mahmoud SMF, El-Tayeb TA, et al.
Cureus · 2026 · Published Erratum
Tayeb HO, Alsawwaf Y, Khoja AA, Batarfi B, et al.
Journal of clinical medicine · 2025 · Journal Article
Barausse C, Tayeb S, Sansavini M, Pellegrino G, et al.
Journal of vitreoretinal diseases · 2025 · Journal Article
Sverdlichenko I, Tayeb S, Cruz Pimentel M, Wahab C, et al.
Cureus · 2025 · Journal Article
Das S, Kotwal V, Thakur A, T L, et al.
Journal of fluorescence · 2025 · Journal Article
Shafie A, Ashour AA, Tayeb FJ, Felemban MF
Medicinal chemistry (Shariqah (United Arab Emirates)) · 2025 · Journal Article
Tayeb FJ, Felemban MF, Ashour AA, Shafie A